EXAGEN INC.

XGN ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $66.6M $55.6M $52.5M $45.6M $48.3M $42.0M $40.4M $32.4M
Cost of Revenue $27.8M $22.5M $23.1M $24.2M $20.6M $16.6M $18.8M $15.4M
Gross Profit $38.8M $33.1M $29.5M $21.3M $27.7M $25.4M $21.6M $17.1M
Gross Margin 58.3% 59.5% 56.1% 46.9% 57.4% 60.6% 53.4% 52.6%
Operating Expenses
Research & Development $6.3M $5.4M $4.9M $9.9M $7.2M $3.6M $2.2M $2.1M
SG&A Expense $46.6M $41.4M $47.4M $52.0M $44.5M $37.0M $28.7M $19.7M
Operating Income $-14.1M $-13.6M $-22.8M $-46.1M $-24.1M $-15.2M $-9.3M $-4.9M
Operating Margin -21.1% -24.5% -43.5% -101.1% -49.8% -36.2% -23.0% -15.0%
Interest Expense $2.3M $2.4M $2.6M $2.6M $3.5M $2.9M
Pretax Income
Income Tax Expense $51.0K $12.0K $33.0K $-282.0K $175.0K $-79.0K $25.0K $58.0K
Net Income $-20.0M $-15.1M $-23.7M $-47.4M $-26.9M $-16.7M $-12.0M $-8.0M
Net Margin -30.0% -27.2% -45.1% -104.0% -55.6% -39.8% -29.8% -24.7%
EPS (Basic) $-0.93 $-0.83 $-1.34 $-2.77 $-1.68 $-1.32 $-8.46 $-293.34
EPS (Diluted) $-0.93 $-0.83 $-1.34 $-2.77 $-1.68 $-1.32 $-8.46 $-293.34
Shares Outstanding (Basic) 21.6M 18.2M 17.7M 17.1M 16.0M 12.6M 12.6M 63.0K
Shares Outstanding (Diluted) 21.6M 18.2M 17.7M 17.1M 16.0M 12.6M 12.6M 63.0K
Dividends Per Share